High-dose propofol reduces S-100β protein and neuron-specific enolase levels in patients undergoing cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 3, 2013, Pages 510-515

  Ma, Gang ^a   Chen, Jinhua ^a   Meng, Xiangkun ^a   Deng, Liqin ^a   Gao, Yuhua ^a   Meng, Jinhai ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

cardiac surgery; cerebral protection; propofol; target controlled infusion

Indexed keywords

CISATRACURIUM; FENTANYL; NEURON SPECIFIC ENOLASE; PROPOFOL; PROTEIN S100B;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY DEVICE; DRUG DOSE COMPARISON; DRUG INFUSION; DRUG MEGADOSE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANESTHETICS, INTRAVENOUS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PROPOFOL; S100 PROTEINS; STERNOTOMY;

EID: 84877757445     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.10.013     Document Type: Article

References (35)

1. Y. Carrascal, and A.L. Guerrero Neurological damage related to cardiac surgery: Pathophysiology, diagnostic tools and prevention strategies. Using actual knowledge for planning the future Neurologist 16 2010 152 164
2. A.E. Van Harten, T.W. Scheeren, and A.R. Absalom A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia Anaesthesia 67 2012 280 293
3. Kaplan JA, Reich DL, Lake CL (eds). Kaplan's Cardiac Anesthesia. 5th ed. Philadelphia, PA, Saunders, 2006
4. D. Georgiadis, A. Berger, and E. Kowatschev Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery J Thorac Cardiovasc Surg 119 2000 138 147
5. S. Korfias, A. Papadimitriou, and G. Stranjalis Serum biochemical markers of brain injury Mini Rev Med Chem 9 2009 227 234
6. H. Abdul-Khaliq, S. Schubert, and G. Stoltenburg-Didinger Protein S-100beta in brain and serum after deep hypothermic circulatory arrest in rabbits: Relationship to perivascular astrocytic swelling Clin Chem Lab Med 38 2000 1169 1172
7. M. Herrmann, N. Curio, and S. Jost Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury Restor Neurol Neurosci 14 1999 109 114
8. J.G. Bovill Intravenous anesthesia for the patient with left ventricular dysfunction Semin Cardiothorac Vasc Anesth 10 2006 43 48
9. I. Vasileiou, T. Xanthos, and E. Koudouna Propofol: A review of its non-anaesthetic effects Eur J Pharmacol 605 2009 1 8
10. Y. Kotani, M. Shimazawa, and S. Yoshimura The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties CNS Neurosci Ther 14 2008 95 106
11. C. Adembri, L. Venturi, and A. Tani Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism Anesthesiology 104 2006 80 89
12. L.J. Velly, B.A. Guillet, and F.M. Masmejean Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: Role of glutamate and its transporters Anesthesiology 99 2003 368 375
13. M. Bauer, W. Wilhelm, and T. Kraemer Impact of bispectral index monitoring on stress response and propofol consumption in patients undergoing coronary artery bypass surgery Anesthesiology 101 2004 1096 1104
14. P. Olivier, D. Sirieix, and P. Dassier Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery: A new approach for scheduled early extubation J Cardiothorac Vasc Anesth 14 2000 29 35
15. A. Lehmann, J. Boldt, and R. Römpert Target-controlled infusion or manually controlled infusion of propofol in high-risk patients with severely reduced left ventricular function J Cardiothorac Vasc Anesth 15 2001 445 450
16. S. Yamamoto, K. Goto, and N. Yasuda Cardiac anesthesia induction by low target plasma concentration setting of propofol using target-controlled infusion Masui 57 2008 691 695
17. Z. Xia, Z. Huang, and D.M. Ansley Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: A comparison with isoflurane Anesth Analg 103 2006 527 532
18. L. Barvais, I. Rausin, and J.B. Glen Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery J Cardiothorac Vasc Anesth 10 1996 877 883
19. S.I. Harik, V.K. Sharma, and J.R. Wetherbee Adrenergic and cholinergic receptors of cerebral microvessels J Cereb Blood Flow Metab 1 1981 329 338
20. Miller RD, Fleisher LA, Johns RA (eds). Miller's Anesthesia. 6th ed. Philadelphia, Elsevier Churchill Livingstone, 2005, pp 837-839
21. H. Xu, M. Aibiki, and S. Yokono Dose-dependent effects of propofol on renal sympathetic nerve activity, blood pressure and heart rate in urethane-anesthetized rabbits Eur J Pharmacol 387 2000 79 85
22. 2+ sensitivity of BKCa in the cerebral arterial smooth muscle cells of mice Acta Pharmacol Sin 33 2012 19 26
23. M.A. Frölich, A. Arabshahi, and C. Katholi Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers J Clin Anesth 23 2011 218 223
24. V. Macquaire, F. Cantraine, and D. Schmartz Target-controlled infusion of propofol induction with or without plasma concentration constraint in high-risk adult patients undergoing cardiac surgery Acta Anaesthesiol Scand 46 2002 1010 1016
25. Y. Liu, Y. Xu, and D.Z. Li Comparison of S100B and NSE between cardiac surgery and interventional therapy for children Pediatr Cardiol 30 2009 893 897
26. M. Bonacchi, E. Prifti, and M. Maiani Does off-pump coronary revascularization reduce the release of the cerebral markers, S-100beta and NSE? Heart Lung Circ 15 2006 314 319
27. F. Gao, DN Harris, and S. Sapsed-Byrne Neuron-specific enolase and Sangtec 100 assays during cardiac surgery: Part I - The effects of heparin, protamine and propofol Perfusion 12 1997 163 165
28. F. Gao, D.N. Harris, and S. Sapsed-Byrne Neuron-specific enolase and Sangtec 100 assays during cardiac surgery: Part III - Does haemolysis affect their accuracy? Perfusion 12 1997 171 177
29. R.M. Chen, T.G. Chen, and T.L. Chen Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages Ann N Y Acad Sci 1042 2005 262 271
30. K.U. Klein, K. Fukui, and P. Schramm Human cerebral microcirculation and oxygen saturation during propofol-induced reduction of bispectral index Br J Anaesth 107 2011 735 741
31. T. Luo, and Z. Xia A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in inducing human vascular endothelial cell apoptosis: reversal with propofol Anesth Analg 103 2006 110 116
32. W.F. Xia, Y. Liu, and Q.S. Zhou Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery Yonsei Med J 52 2011 326 332
33. Z. Xia, D.V. Godin, and D.M. Ansley Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity Can J Physiol Pharmacol 82 2004 919 926
34. T. Yano, R. Nakayama, and K. Ushijima Intracerebroventricular propofol is neuroprotective against transient global ischemia in rats: Extracellular glutamate level is not a major determinant Brain Res 883 2000 69 76
35. M. Berns, L. Seeberg, and M. Schmidt High-dose propofol triggers short-term neuroprotection and long-term neurodegeneration in primary neuronal cultures from rat embryos J Int Med Res 37 2009 680 688